country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-157577

Copy Link Print Information

PROTAC(H-PGDS)-8

PROTAC (H-PGDS)-8 is an H-PGDS PROTAC inhibitor with a IC₅₀ of 0.14 μM. PROTAC (H-PGDS)-8 binds to H-PGDS and inhibits its enzymatic activity. PROTAC (H-PGDS)-8 inhibits the production of PGD₂ in cancer cells. PROTAC (H-PGDS)-8 can be used for the research of Duchenne muscular dystrophy.
(Pink: Target protein ligand; Blue: Cereblon ligand (HY-W460193); Black: linker).

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 2761281-51-8
Formel: C₄₁H₄₀N₈O₇
Molecular Weight:756.81

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (274 KB)

PROTAC(H-PGDS)-8 Chemical Structure

CAS. Nr.: 2761281-51-8

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- In Vitro
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

PROTAC (H-PGDS)-8 is an H-PGDS PROTAC inhibitor with a IC₅₀ of 0.14 μM. PROTAC (H-PGDS)-8 binds to H-PGDS and inhibits its enzymatic activity. PROTAC (H-PGDS)-8 inhibits the production of PGD₂ in cancer cells. PROTAC (H-PGDS)-8 can be used for the research of Duchenne muscular dystrophy^[1]. (Pink: Target protein ligand; Blue: Cereblon ligand (HY-W460193); Black: linker).

IC₅₀ & Target^[1]

H-PGDS

0.14 μM (IC₅₀)

Alle PROTACs Isoform-spezifische Produkte anzeigen :

Alle Prostaglandin Receptor Isoform-spezifische Produkte anzeigen :

In Vitro

PROTAC(H-PGDS)-8 (0-10000 pM; 6 h) does not induce degradation of H-PGDS protein in KU812 cells at concentrations up to 10000 pM over 6 h^[1].
PROTAC(H-PGDS)-8 (2.44 nM-2.50 μM; 1 h) binds to recombinant human H-PGDS protein with an IC₅₀ of 0.14 μM^[1].
PROTAC(H-PGDS)-8 (100-3000 pM; 6 h) suppresses PGD₂ production in KU812 cells at concentrations ≥1000 pM after 6 h incubation, with less potent activity than PROTAC(H-PGDS)-7 (compound 6)^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis^[1]

Cell Line:

KU812 cells
Concentration:

0, 10, 100, 1000, 10000 pM
Incubation Time:

6 h
Result:

Showed no reduction of H-PGDS protein levels across all tested concentrations and incubation time, with H-PGDS expression remaining at ~90-100% of the DMSO-treated control.

Chemical Information

CAS. Nr. 2761281-51-8
Molecular Weight 756.81
Formel C₄₁H₄₀N₈O₇
SMILES

O=C(C1CCN(CC1)C2=CC=C(C=C2)NC(C3=CN=C(N=C3)OC4=CC=CC=C4)=O)N5CCN(CC5)C6=C(C7=CC=C6)C(N(C7=O)C8CCC(N(C8=O)C)=O)=O
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (274 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. Yokoo H, et al. Discovery of a Highly Potent and Selective Degrader Targeting Hematopoietic Prostaglandin D Synthase via In Silico Design. Journal of medicinal chemistry. 2021 Nov 11;64(21):15868-15882. [Content Brief]

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen

Amount: USD 0.00

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- In Vitro
Chemical Information
Reinheit & Dokumentation
Verweise

Produktname:
Art. -Nr.:
Menge:
MCE Japan Authorized Agent:

Produktname:
CAS. Nr.:
Species:
Reinheit:
Menge:

PROTAC(H-PGDS)-8

Alle PROTACs Isoform-spezifische Produkte anzeigen

Alle Prostaglandin Receptor Isoform-spezifische Produkte anzeigen

Biologische Aktivität

Chemical Information

Reinheit & Dokumentation

Verweise

Calculators

Help & FAQs

PROTAC(H-PGDS)-8 Related Classifications

HY-157577 Related Classifications